Found 8 matching trials
Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells
PHASE1Chimeric antigen receptor (CAR)-modified T cells targeted against CD19 have...
Location
District One Hospital
CD7-specific CAR-T Cell in the Treatment of CD7-positive Relapsed/Refractory Hematologic Tumors
PHASE1This study is a single-center, open, prospective single-arm clinical study ...
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Cell Therapy for CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD7-Specific CAR-T Cells
PHASE1This is an open, single-arm, clinical study to evaluate efficacy and safety...
Location
Hebei yanda Ludaopei Hospital
Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies
PHASE1Phase 1/2 umbrella study evaluates biomarker-selected dual-target CAR-T cel...
Location
Peking University Shenzhen Hospital
Cell Therapy for CD7 Positive Acute Myeloid Leukemia or Mixed Lineage Leukemia
NAThis is an open, single-arm, clinical study to evaluate efficacy and safety...
Location
He bei Yan da Lu dao pei Hospital
Cell Therapy for High Risk T-Cell Malignancies Using CD7-Specific CAR Expressed On Autologous T Cells
PHASE1Patients eligible for this study have a type of blood cancer called T-cell ...
Status
Active Not Recruiting
Location
Houston Methodist Hospital
Novel Unedited Allo Cell Therapy For High Risk T-Cell Malignancies Using CD7-Specific Car T Cells
PHASE1Patients eligible for this study have a type of blood cancer called T-cell ...
Location
Houston Methodist Hospital
Multi-omics Profiling of Patients With Aplastic Anemia Before and After CD7-CAR-T Therapy
N/AAplastic anemia (AA) is a life-threatening bone marrow failure disorder cha...
Status
Active Not Recruiting
Location
Xuzhou Medical University